Tony Hoang
Obstetrics & Gynecology · Bakersfield, CANPI 1609069947
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.6% of the total across 208 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $937 and has fallen 58.4% since, to $389 in 2025.
Across 208 payments — averaging $20.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$919
- Hologic Sales And Service, LLC$598
- Therapeuticsmd, Inc.$396
- Acessa Health Inc.$246
- Evofem Biosciences, Inc.$209
- Mayne Pharma Commercial LLC$195
- plus $2K from 23 others
What the payments were for
- Travel & lodging$3468%
- Food & beverage$3,93292%
- Education$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 51 | $919 |
| Hologic Sales And Service, LLC | 20 | $598 |
| Therapeuticsmd, Inc. | 24 | $396 |
| Acessa Health Inc. | 1 | $246 |
| Evofem Biosciences, Inc. | 20 | $209 |
| Mayne Pharma Commercial LLC | 14 | $195 |
| Sumitomo Pharma America, Inc. | 8 | $184 |
| Abbott | 6 | $147 |
| Acell, Inc. | 5 | $144 |
| Myovant Sciences Inc. | 7 | $141 |
| Pfizer | 6 | $136 |
| Minerva Surgical, Inc | 5 | $104 |
| Sage Therapeutics, LLC | 4 | $96 |
| Shield Therapeutics Inc | 4 | $90 |
| Stimlabs LLC | 2 | $78 |
| Boston Scientific | 2 | $76 |
| Avion Pharmaceuticals | 5 | $76 |
| Organon | 4 | $73 |
| Merck | 4 | $71 |
| Ascend Therapeutics US, LLC | 4 | $69 |
| Lupin Inc. | 3 | $56 |
| Astellas Pharma US Inc | 2 | $54 |
| Channel Medsystems, Inc. | 1 | $24 |
| Agile Therapeutics, Inc. | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Bayer | 1 | $21 |
| GSK | 1 | $16 |
| Smith+Nephew | 1 | $15 |
| Novo Nordisk | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,295 in reported general payments places this provider in the 85th percentile of 3,784 obstetrics & gynecology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 14 | $197 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Bakersfield
- Rahul SharmaBakersfield$60K
- Steve YuNorthridge$964K
- Samir HageRedlands$640K
- Malcolm MunroLos Angeles$609K
- Michael KrychmanCosta Mesa$547K
- Anita NelsonTorrance$530K
- Jan SegnitzSan Jose$511K
- Risa KaganBerkeley$497K
- Michael GreenOxnard$424K
- Howard SalvaySanta Cruz$421K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.